3rd EURORDIS Multi-Stakeholder Symposium on Improving Patients’ Access to Rare Disease Therapies
Let’s make a pact to ensure patients’ sustainable access to rare disease therapies
13-14 February 2019 Crowne Plaza Brussels – Le Palace, Rue Gineste 3, 1210 Brussels, Belgium
Metro Station: RogierFinal Programme
Over 250 people gathered at this event, including rare disease patients, patient advocates, healthcare industry, consultants, investors, ERN clinical representatives, academia, healthcare professionals, researchers, payer bodies, HTA agencies, National Competent Authorities, regulators, policy makers, and government workers.
Some of the important take-home messages include the recognition that multi-stakeholder collaboration is a fundamental condition to achieving patient access to rare disease medicines; that there is a need for a more trusted and transparent cooperation between payers and companies; and that the expectations for the European Reference Networks (ERNs) to be an important facilitator in evidence generation building is also an area of high interest that will be monitored closely over the coming years.
EURORDIS-Rare Diseases Europe is now gathering the input developed in the plenary and breakout sessions and will include them in the outcomes document as a roadmap for all parties to collaborate in a process to improve patients’ access to rare disease medicines. The final version of the roadmap document will be shared in April 2019.
Two webinars have taken place ahead of this Symposium to provide the knowledge needed to effectively participate in discussions at the event.
First pre-symposium webinar
Covering topics in breakout sessions 2 and 3. Webinar speakers:
Anna Bucsics, University of Vienna; Project Advisor, Mechanism of Coordinated Access to orphan medicinal products (MoCA)
Simone Boselli, Public Affairs Director, EURORDIS-Rare Diseases Europe
Second pre-symposium webinar
Covering topics in breakout sessions 1 and 4. Webinar speakers:
Victoria Hedley, Newcastle University, Rare Disease Policy Manager, Newcastle University John Walton Muscular Dystrophy Research Centre, MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine
Simone Boselli, Public Affairs Director, EURORDIS-Rare Diseases Europe